Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Marté JL"'
Autor:
Rajan A; Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Abdul Sater H; Cleveland Clinic, Stuart, Florida, USA., Rahma O; AstraZeneca, Boston, Massachusetts, USA., Agajanian R; Innovative Clinical Research Institute, Whittier, California, USA., Lassoued W; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Marté JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Tsai YT; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Donahue RN; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lamping E; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bailey S; University of Maryland School of Medicine, Baltimore, Maryland, USA., Weisman A; Axle Informatics, Bethesda, Maryland, USA., Walter-Rodriguez B; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Ito R; Merck Biopharma Co., Ltd; an affiliate of Merck KGaA, Tokyo, Japan., Vugmeyster Y; EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, Billerica, Massachusetts, USA., Sato M; Merck Biopharma Co., Ltd; an affiliate of Merck KGaA, Tokyo, Japan., Machl A; EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, Billerica, Massachusetts, USA., Schlom J; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gulley JL; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA gulleyj@mail.nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Mar 13; Vol. 12 (3). Date of Electronic Publication: 2024 Mar 13.
Autor:
Gatti-Mays ME; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Tschernia NP; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Madan RA; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Karzai FH; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Bilusic M; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Redman J; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sater HA; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Floudas CS; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Toney NJ; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Marté JL; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Francis D; Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., McMahon S; Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Lamping E; Office of Research Nursing, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Cordes L; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gulley JL; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Apr 06; Vol. 28 (4), pp. 364-e217.
Autor:
Goswami M; National Heart Lung and Blood Institute, Bethesda, Maryland, USA.; National Cancer Institute, Bethesda, Maryland, USA., Gui G; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Dillon LW; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Lindblad KE; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Thompson J; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Valdez J; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Kim DY; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Ghannam JY; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Oetjen KA; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Destefano CB; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Smith DM; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Tekleab H; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Li Y; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Dagur P; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Hughes T; National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Marté JL; National Cancer Institute, Bethesda, Maryland, USA., Del Rivero J; National Cancer Institute, Bethesda, Maryland, USA., Klubo-Gwiezdzinksa J; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA., Gulley JL; National Cancer Institute, Bethesda, Maryland, USA., Calvo KR; National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Lai C; National Heart Lung and Blood Institute, Bethesda, Maryland, USA., Hourigan CS; National Heart Lung and Blood Institute, Bethesda, Maryland, USA hourigan@nih.gov.; Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
Autor:
DeMaria PJ; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lee-Wisdom K; Medical Oncology Service, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Madan RA; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Karzai F; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schwab A; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Palena C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Floudas C; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Marté JL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Redman JM; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Dombi E; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Widemann B; Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Korchin B; Oncology Strategy, Bavarian Nordic Inc, Morrisville, North Carolina, USA., Adams T; Bavarian Nordic GmbH, Martinsried, Bayern, Germany., Pico-Navarro C; Oncology Strategy, Bavarian Nordic Inc, Morrisville, North Carolina, USA., Heery C; Arcellix, Inc, Gaithersburg, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bilusic M; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA marijo.bilusic@nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Sep; Vol. 9 (9).
Autor:
DeMaria PJ; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Park DM; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; University of Chicago, Chicago, Illinois, USA., Heery CR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Precision Biosciences, Durham, North Carolina, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bagheri MH; Clinical Image Processing Service, National Institutes of Health, Bethesda, Maryland, USA., Strauss J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Shen V; Clinical Image Processing Service, National Institutes of Health, Bethesda, Maryland, USA., Marté JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
The oncologist [Oncologist] 2021 May; Vol. 26 (5), pp. e847-e858. Date of Electronic Publication: 2021 Mar 09.
Autor:
Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Marté JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Goswami M; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Toney NJ; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Tsai YT; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA schlomj@mail.nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Autor:
Bilusic M; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA marijo.bilusic@nih.gov., McMahon S; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Madan RA; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Karzai F; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Tsai YT; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Palena C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Jochems C; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Marté JL; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Floudas C; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Strauss J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Redman J; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Abdul Sater H; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Rabizadeh S; ImmunityBio, Culver City, California, USA., Soon-Shiong P; ImmunityBio, Culver City, California, USA., Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Autor:
Madan RA; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA madanr@mail.nih.gov., Karzai F; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Al-Harthy M; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Bilusic M; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Rosner II; The Center for Prostate Disease Research, Walter Reed National Military Medical Center, Bethesda, Maryland, USA., Singh H; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Arlen PM; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Theoret MR; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Marté JL; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Cordes L; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Couvillon A; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Hankin A; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Williams M; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Owens H; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Lochrin SE; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Chau CH; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Steinberg S; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Figg WD; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Dahut W; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Autor:
Strauss J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gatti-Mays ME; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Cho BC; Yonsei University College of Medicine, Seoul, Republic of Korea., Hill A; Tasman Oncology Research Ltd, Southport, Queensland, Australia., Salas S; CEPCM Assistance Publique des Hôpitaux de Marseille; Aix-Marseille Université, Marseille, France., McClay E; California Cancer Associates for Research and Excellence, Encinitas, California, USA., Redman JM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Sater HA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Jochems C; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lamping E; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Burmeister A; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Leidos Biomedical Research, Frederick, Maryland, USA., Marté JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Karzai F; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Ojalvo LS; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA; an affiliate of Merck KGaA, Darmstadt, Germany., Jehl G; Merck KGaA, Darmstadt, Germany., Rolfe PA; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA; an affiliate of Merck KGaA, Darmstadt, Germany., Hinrichs CS; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA gulleyj@mail.nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Dec; Vol. 8 (2).
Autor:
Marté JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Toney NJ; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Cordes L; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA gulleyj@mail.nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Nov; Vol. 8 (2).